& FitzGerald, D
Caution is also advised for patients with a history of pancreatitis, gastroparesis, diabetic ketoacidosis and hypersensitivity reactions
doi: 10.3389/fphar.2022.856111 Received 16 January 2022 Accepted 15 February 2022 Published 08 March 2022 Volume 13 - 2022 Edited by Giuseppe Paolisso, University of Campania Luigi Vanvitelli, Italy Reviewed by Stefano Ciardullo, University of Milano Bicocca, Italy Maria Rosaria Rizzo, University of Campania Luigi Vanvitelli, Italy Updates Copyright 2022 Pahud de Mortanges, Sinaci, Salvador, Bally, Muka, Wilhelm and Bano
Contact your GP or prescriber promptly if you experience: No measurable weight loss or metabolic improvement after several months at the target maintenance dose Persistent nausea, vomiting, or diarrhoea that is not improving with dose titration severe or prolonged vomiting and diarrhoea can cause dehydration
Despite the promising results, its important to note that the absorption rate of oral glutathione can vary from person to person